The expression of corticotropin-releasing hormone in melanoma

Pigment Cell Research

Volumn 15, Issue 2, 2002, Pages 98-103

  Sato, Hirofumi ^a   Nagashima, Yoji ^b   Chrousos, George P ^c   Ichihashi, Masamitsu ^a   Funasaka, Yoko ^a  

^a KOBE UNIVERSITY   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Agonist; Antagonist; Immunohistochemistry; POMC

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING HORMONE (9 41); CORTICOTROPIN RELEASING HORMONE (9-41); HORMONE ANTAGONIST; PEPTIDE FRAGMENT; PROOPIOMELANOCORTIN;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MELANOMA; METABOLISM; METASTASIS; PATHOLOGY; SKIN;

CORTICOTROPIN-RELEASING HORMONE; GENE EXPRESSION REGULATION, NEOPLASTIC; HORMONE ANTAGONISTS; HUMANS; MELANOMA; NEOPLASM METASTASIS; PEPTIDE FRAGMENTS; PRO-OPIOMELANOCORTIN; SKIN; TUMOR CELLS, CULTURED;

EID: 0036097226     PISSN: 08935785     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0749.2002.1o063.x     Document Type: Article

References (52)

1. Common precursor to corticotropins and endorphins
2. β-lipotropin is the major opioid-like peptide of human pituitary and rat pars distalis: Lack of significant β-endorphin
3. Human lymphocytes produce pro-opiomelanocortin gene-related transcripts. Effects of lymphotropic viruses
4. Anchorage-independent growth of murine melanoma in serum-less media is dependent on insulin or melanocyte-stimulating hormone
5. Experimental metastasis correlates with cyclic AMP accumulation in B16 melanoma clones
6. Increased experimental metastatic capacity of a murine melanoma following induction of differentiation
7. α-melanocyte-stimulating hormone immunoreactivity in melanoma cells
8. MSH receptor expression and the relationship to melanogenesis and metastatic activity in B16 melanoma
9. Expression of α-melanocyte stimulating hormone and the invasive ability of the B16 murine melanoma
10. Immunoreactivity of α-melanocyte-stimulating hormone, adrenocorticotrophic hormone and β-endorphin in cutaneous malignant melanoma and benign melanocytic naevi
11. Proopiomelanocortin, corticotropin releasing hormone and corticotropin releasing hormone receptor genes are expressed in human skin
12. Expression of proopiomelanocortin, corticotropin-releasing hormone (CRH), and CRH receptor in melanoma cells, nevus cells, and normal human melanocytes
13. c-KIT receptor expression in cutaneous malignant melanoma and benign melanotic naevi
14. Corticotropin-releasing hormone production by a small cell carcinoma in a patient with ACTH-dependent Cushing's syndrome
15. Establishment and characterization of a malignant melanoma cell line (YP-MEL) derived from a patient with neurocutaneous melanosis
16. HLA-DR melanoma-associated antigen (p97) expression during the cell cycle in human melanoma cell lines, and the effects of recombinant γ-interferon: Two-color flow cytometric analysis
17. Changes in the expression of the type-2 but not the type-1 cyclo-oxygenase enzyme in chorion-decidua with the onset of labour
18. Production and release of proopiomelanocortin (POMC) derived peptides by human melanocytes and keratinocytes in culture: Regulation by ultraviolet B
19. Chemical and biological characterization of corticotropin releasing factor
20. Hypothalamic control of adrenocorticotropin secretion: Advances since the discovery of 41-residue corticotropin-releasing factor
21. Corticotropin-releasing factor (CRF) -like immunoreactivity in the vertebrate endocrine pancreas
22. Corticotropin-releasing factor (CRF) -like immunoreactivity in the gastro-entero-pancreatic endocrine system
23. Distribution and characterization of immunoreactive corticotropin-releasing factor in human tissues
24. Expression of adrenocorticotropin-releasing hormone precursor gene in placenta and other nonhypothalamic tissues in man
25. Corticotropin-releasing factor is produced by rat Leydig cells and has a major local antireproductive role in the testis
26. Corticotropin-releasing hormone in humans
27. Immunoreactive corticotropin-releasing hormone and its binding sites in the rat ovary
28. Presence of immunoreactive corticotropin-releasing hormone in normal and polycystic human ovaries
29. Presence of immunoreactive corticotropin releasing hormone in thyroid lesions
30. The corticotropin-releasing hormone (CRH) in normal and tumoral epithelial cells of human endometrium
31. Corticotropin-releasing factor decreases plasma luteinizing hormone levels in female rats by inhibiting gonadotropin-releasing hormone release into hypophysial-portal circulation
32. Inhibin-mediated feedback control of follicle-stimulating hormone secretion in the female rat
33. Characterization of corticotropin-releasing hormone (CRH) in human skin
34. Rat corticotropin-releasing hormone gene: Sequence and tissue-specific expression
35. Physiology and pharmacology of corticotropin-releasing factor
36. Hormonal regulation of human corticotropin-releasing hormone gene expression: Implications for the stress response and immune/inflammatory reaction
37. Endometrial corticotropin-releasing hormone. Its potential autocrine and paracrine actions
38. Potential mechanism of skin reponse to stress
39. Liquid chromatography-mass spectrometry detection of corticotropin-releasing hormone and proopiomelanocortin-derived peptides in human skin
40. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress
41. Neuroendocrinology of the skin
42. Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin and CRH receptors
43. In situ expression of corticotropin-releasing hormone (CRH) and proopiomelanocorti (POMC) genes in human skin
44. A molecular basis for bidirectional communication between the immune and neuroendocrine systems
45. Evidence for the differential expression of the functional α-melanocyte-stimulating hormone receptor MC-1 on human monocytes
46. Melanoma cell expression of Fas (Apo-1/CD95) ligand: Implications for tumor immune escape
47. Proopiomelanocortin-derived peptides are synthesized and released by human keratinocytes
48. Differential cellular regulation of pro-opiomelanocortin by interleukin-1-β and corticotropin-releasing hormone
49. Corticotropin-releasing hormone, luteinizing hormone-releasing hormone, growth hormone-releasing hormone, and somatostatin-like immunoreactivities in biopsies from breast cancer patients
50. Tyrosinase-related protein 2 as a mediator of melanoma specific resistance to cis-diamminedichloroplatinum (II): Therapeutic implications
51. Corticotropin-releasing hormone stimulates angiogenesis and epithelial tumor growth in the skin
52. Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo